GGrantIndex
Sort

326,823 grants matching clinical trial

REDUCING AGGRESSION IN MILITARY PERSONNEL: A RANDOMIZED CLINICAL TRIAL

$1,560,218
The University Of Texas Health Science Center At San Antonio · · FY2025 · Defense Health Agency

Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease

$1,560,188
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM

$1,560,137
Rebecca Schnall · Columbia University Health Sciences · U01 · FY2018 · MD

University of Cincinnati AIDS Clinical Trials Unit- UC ACTU

$1,560,131
Carl J Fichtenbaum · University Of Cincinnati · UM1 · FY2013 · AI

Building on the success of the adoptive immunotherapy of cancer

$1,560,072
Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Georgia CaRes

$1,560,052
Sharad A. Ghamande · Augusta University · UG1 · FY2021 · CA

Peruvian/Brazilian Amazon Center of Excellence in Malaria

$1,560,000
Joseph M. Vinetz · University Of California, San Diego · U19 · FY2010 · AI

Winship Cancer Institute Cancer Center Support Grant

$1,560,000
Walter John Curran · Emory University · P30 · FY2014 · CA

Winship Cancer Institute Cancer Center Support Grant

$1,560,000
Walter John Curran · Emory University · P30 · FY2015 · CA

In-Office, Ultrasound-Based Breakage and Removal of Urinary stones

$1,559,981
Michael R Bailey · University Of Washington · P01 · FY2023 · DK

Modulation of Muscle Growth for the Muscular Dystrophies

$1,559,950
Hugh Lee Sweeney · University Of Pennsylvania · U54 · FY2007 · AR

Topical Neurokinin-1 Receptor Antagonist as an Effective Non-addictive Analgesic for Ocular Pain

$1,559,917
Reza Dana · Schepens Eye Research Institute · R61 · FY2024 · NS

In-Office, Ultrasound-Based Breakage and Removal of Urinary stones

$1,559,862
Michael R Bailey · University Of Washington · P01 · FY2022 · DK

AIDS CLINICAL TRIALS UNIT

$1,559,846
Stanford University · U01 · FY2005 · AI

Development of Recombinant Toxins to Treat Hematologic Malignancies

$1,559,707
Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Pre-DETERMINE: Biologic Markers and MRI SCD Cohort Study

$1,559,652
Christine M Albert · Brigham And Women'S Hospital · R01 · FY2017 · HL

Mental Health Research Network III

$1,559,627
Gregory E Simon · Kaiser Foundation Research Institute · U19 · FY2023 · MH

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,559,527
Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2010 · RR

Investigation of viral and host determinants of gammaherpesvirus pathogenesis

$1,559,522
Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Approaches to Tolerance of Allogeneic Kidney and Islet Transplants

$1,559,520
A Benedict Cosimi · Massachusetts General Hospital · U19 · FY2012 · AI

Recanalization Therapies and Markers of Stroke Outcome

$1,559,517
Joseph Paul Broderick · University Of Cincinnati · P50 · FY2012 · NS

Coordination and Statistics for CoQ10 in HD [2CARE]

$1,559,458
Michael P McDermott · University Of Rochester · R01 · FY2008 · NS

Responsive Neurostimulation for Treatment Resistant Depression

$1,559,435
Andrew D Krystal · University Of California, San Francisco · UH3 · FY2025 · NS

AIM BACK UH3 Transition

$1,559,316
Steven Z George · Duke University · UH3 · FY2022 · AT

HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation

$1,559,239
Christine Marie Durand · Johns Hopkins University · U01 · FY2018 · AI